Female Genital Diseases Completed Phase 2 / 3 Trials for Bismuth subsalicylate (DB01294)

IndicationStatusPhase
DBCOND0040170 (Female Genital Diseases)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02099006Novel Topical Therapies for the Treatment of Genital PainTreatment